WO2023166485 - FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2023/166485
Publication Date
07.09.2023
International Application No.
PCT/IB2023/052005
International Filing Date
03.03.2023
Title **
[English]
FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF
[French]
COMBINAISONS, MÉLANGES ET COMPOSITIONS FONGIQUES ET UTILISATIONS ASSOCIÉES
Applicants **
ADAMA MAKHTESHIM LTD.
P.O. Box 60
8410001 Beer Sheva, IL
Inventors
CONESE, Salvatore
Friesenstrasse 24A
30161 Hannover, DE
ROSENMUND, Alexandra
Arminstrasse 8
8050 Zurich, CH
Priority Data
63/316,366
03.03.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 3101 | |
| EPO | Filing, Examination | 21013 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 13210 |
Total: 38489 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention provides fungicidal combination comprising: (i) an amount of a compound of Formula I (I) and (ii) an amount of at least one fungicide (A) selected from the group consisting of pyrimidines, antibiotics, anilinopyrimidines (AP), aromatic hydrocarbons, aryl- phenylketones, azanaphthalenes, benzamides, benzenesulfonamides, benzo- thiadiazoles (BTH), carboxylic acid amides (CAA), carbamates, cyanoacetamideoxime, dicarboximides, dithiolanes, growth regulators, guanidines, heteroaromatics, inorganics, methyl benzimidazole carbamates (MBC), melanin biosynthesis inhibitors (MBI), membrane disruptors, organo tin compounds, oxysterol binding protein homologue inhibition (OSBPI), phenylamides (PA), phenylacetamides, phenylureas, phosphonates, polyoxins, phenylpyrroles, uncouplers of oxidative phosphorylation, dithianon, sulphur, bordeaux-mixture, thiram, zineb, ziram, famoxadone, fenamidone, pyribencarb, ametoctradin, diniconazole, penconazole, triadimefon, triadimenol, triflumizole, bromuconazole, imazalil, tridemorph, flutolanil, thifluzamide and metominostrobin.[French]
La présente invention concerne une combinaison fongique comprenant : (i) une quantité d'un composé de formule I (I) et (ii) une quantité d'au moins un fongicide (A) choisi dans le groupe constitué par les pyrimidines, les antibiotiques, les anilinopyrimidines (AP), les hydrocarbures aromatiques, les aryl-phénylcétones, les azanaphtalènes, les benzamides, les benzènesulfonamides, les benzo-thiadiazoles (BTH), les amides d'acide carboxylique (CAA), les carbamates, la cyanoacétamideoxime, les dicarboximides, les dithiolanes, les régulateurs de croissance, les guanidines, les hétéroaromatiques, les matières inorganiques, les carbamates de méthylbenzimidazole (MBC), les inhibiteurs de biosynthèse de mélanine (MBI), les perturbateurs de membrane, les composés organo-étain, l’inhibition de la protéine de liaison à l'oxystérol (OSBPI), les phénylamides (PA), les phénylacétamides, les phénylurées, les phosphonates, les polyoxines, les phénylpyrroles, les agents découplants de la phosphorylation oxydative, les dithianons, le soufre, la bouillie bordelaise, le thirame, le zinèbe, le zirame, la famoxadone, le fénamidone, le pyribencarb, l'amétoctradine, le diniconazole, le penconazole, le triadiméfon, le triadiménol, le triflumizole, le bromuconazole, l'imazalil, le tridémorphe, le flutolanil, le thifluzamide et la métominostrobine.